Heterocyclic Building Blocks

Sulfur-Containing Heterocycles

Thienopyridine Derivatives Thiophene Derivatives

Indole Derivatives

Spiro cyclic Heterocycles

Bridged Bicyclic Heterocycles

Pidine Derivatives

Pyridine Derivatives

Isoquinoline Derivatives

Fused Bicyclic Heterocycles

Pyridine Derivatives

Pyrazole Derivatives

Sulfur-Containing Heterocycles

Thiophene Derivatives

Fused Bicyclic Heterocycles

Azepine Derivatives

Benzazepines

Pyridazine Derivatives

Fused Bicyclic Heterocycles

Pyrazolo-pyrimidine Derivatives Isoquinoline Derivatives Pyrrolopyrimidine Derivatives Pyrrolopyridine Derivatives Imidazopyridine Derivatives Pyrazolo-pyridine Derivatives

Sulfur-Containing Heterocycles

Spiro cyclic Heterocycles

Coumarin Derivatives

Pyrrole Derivatives

Benzoxaborole Derivatives

Pyridone Derivatives

Oncology Drug Intermediates

Enzyme Inhibitor Intermediates

Kinase Inhibitors

En Inhibitor Intermediates

Kinase Inhibitors

Alkylating Agents

Cytotoxic Natural Products

Neurological Intermediates

Anticonvulsants

Cardiovascular Intermediates

Cardiac Glycosides

Vasodilator Intermediates

Angiotensin II Receptor Blockers

Calcium Channel Blockers

Organic Synthesis Intermediates

Nitrile Intermediates

Heterocyclic Building Blocks

Quinoline Derivatives

Aromatic Alcohols

Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Nitro Aromatic Alcohols Nitro Aromatic Alcohols Nitro Aromatic Alcohols Halogenated Aromatic Alcohols

Ketone Intermediates

Antidiabetic Intermediates

Antimalarial Intermediates

Amide Intermediates

Benzamide Derivatives

Enzyme Inhibitor Intermediates

Kinase Inhibitors

Carbonic Anhydrase Inhibitors

Nitro Aromatic Derivatives

Drug Discovery Reagents

Antimalarial Intermediates

Oncology Drug Intermediates

Enzyme Inhibitor Intermediates

Sulfonamide Intermediates

Neurological Research Reagents

Heterocyclic Building Blocks

Antihistamine Intermediates

Phenolic Intermediates

Halogenated Phenols

Aliphatic Carboxylic Acid Derivatives

Malonic Acid Derivatives

Drug Delivery Intermediates

Surface Modification Reagents

REAGENT

(S)-Methyl 3-amino-3-(3,4-dichlorophenyl)propanoate hydrochloride

95%

CAS:2565792-38-1

Formula:C₁₀H₁₂Cl₃NO₂

MW:284.57 g/mol

฿12,140.00

View

REAGENT

2-(Methoxymethyl)-4-nitro-1,2,3,5,6,7-hexahydro-s-indacene

97%

CAS:2676865-19-1

Formula:C₁₄H₁₇NO₃

MW:247.29 g/mol

฿4,300.00

View

REAGENT

(8-Amino-1,2,3,5,6,7-hexahydro-s-indacen-1-yl)methanol

97%

CAS:2676864-14-3

Formula:C₁₃H₁₇NO

MW:203.28 g/mol

฿3,310.00

View

REAGENT

(S)-2-(Benzo[b]thiophen-2-yl)-4-isobutyl-4,5-dihydrooxazole

95%

CAS:2828438-78-2

Formula:C₁₅H₁₇NOS

MW:259.37 g/mol

฿4,810.00

View

REAGENT

(S)-2-Amino-2-(3,5-dibromophenyl)ethan-1-ol hydrochloride

95%

CAS:2703746-43-2

Formula:C₈H₁₀Br₂ClNO

MW:331.43 g/mol

฿22,050.00

View

REAGENT

(S)-2-(5-Bromopyridin-2-yl)-4-isopropyl-4,5-dihydrooxazole

97%, 99% e.e.

CAS:2757083-25-1

Formula:C₁₁H₁₃BrN₂O

MW:269.14 g/mol

฿13,340.00

View

REAGENT

(S)-2-(5-Chloropyridin-2-yl)-4-isopropyl-4,5-dihydrooxazole

97%, 99% e.e.

CAS:2757083-19-3

Formula:C₁₁H₁₃ClN₂O

MW:224.69 g/mol

฿10,830.00

View

REAGENT

(1S,9S)-1-Amino-9-ethyl-5-fluoro-9-hydroxy-4-methyl-1,2,3,9,12,15-hexahydro-10H,13H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-10,13-dione methanesulfonate dihydrate

95%

CAS:197720-53-9

Formula:C₂₅H₂₈FN₃O₈S

MW:549.57 g/mol

฿17,300.00

View

REAGENT

(S)-Methyl 2-(4-hydroxy-4-methylisoxazolidine-2-carbonyl)benzoate

97%

CAS:644970-78-5

Formula:C₁₃H₁₅NO₅

MW:265.26 g/mol

฿11,730.00

View

REAGENT

rel-(3aS,6aS)-5-Benzylhexahydro-2H-thieno[2,3-c]pyrrole 1,1-dioxide

97%

CAS:1320326-66-6

Formula:C₁₃H₁₇NO₂S

MW:251.34 g/mol

฿11,400.00

View

Cart

No products

Subtotal: 0.00

Total 0.00 THB

Cart Checkout

Researcher Network Do you belong to Researcher Network? Use your organization email to unlock organization invoice requirements and eligibility. View details